4//SEC Filing
Kurkijarvi Kalevi 4
Accession 0001209191-20-065571
CIK 0000921299other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 6:07 PM ET
Size
13.9 KB
Accession
0001209191-20-065571
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Kurkijarvi Kalevi
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-12-28−1→ 11,999 totalExercise: $19.05Exp: 2026-06-08→ Common Stock (1 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-28−6,000→ 0 totalExercise: $18.34Exp: 2025-06-03→ Common Stock (6,000 underlying) - Sale
Common Stock
2020-12-28$41.14/sh−100$4,114→ 33,100 total - Exercise/Conversion
Common Stock
2020-12-28$19.05/sh+1$19→ 39,101 total - Exercise/Conversion
Common Stock
2020-12-28$18.34/sh+6,000$110,040→ 39,100 total - Sale
Common Stock
2020-12-28$40.39/sh−5,901$238,341→ 33,200 total
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices ranging from $40.00 to $40.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Fully vested.
Documents
Issuer
FIBROGEN INC
CIK 0000921299
Entity typeother
Related Parties
1- filerCIK 0001621333
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 6:07 PM ET
- Size
- 13.9 KB